{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:55:28Z","timestamp":1789707328861,"version":"4.0.1"},"reference-count":45,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Objectives: This study evaluated the therapeutic potential of topical Ripasudil hydrochloride hydrate in managing various forms of corneal edema. Methods: This retrospective study included 96 patients of 72.20 \u00b1 10.52 years, with 53 females (55.2%) who were treated with Ripasudil for corneal edema, with a mean treatment duration of 5.2 \u00b1 2.3 months, divided into four groups: post-cataract surgery (n = 32), Fuchs endothelial corneal dystrophy (FECD; n = 29), post-Descemet membrane endothelial keratoplasty (DMEK; n = 25), and post-penetrating keratoplasty (PKP; n = 10). All patients were treated with Ripasudil, typically administered three times daily in the first week and twice daily in the following months. Clinical efficacy outcomes were assessed using changes in best-corrected visual acuity (BCVA), central corneal thickness (CCT), and endothelial cell count (ECC) with specular microscopy, anterior segment optical coherence tomography (OCT), and slit-lamp examination, while intraocular pressure (IOP) was measured using the iCare tonometer. Results: Ripasudil treatment led to a reduction in CCT and improvement in visual acuity across most groups, with minimal changes in ECC. CCT decreased by 30.44 \u03bcm (p &lt; 0.001), 25.56 \u03bcm (p &lt; 0.001), 8.41 \u03bcm (p = 0.05), and 6.80 \u03bcm (p &gt; 0.1); visual acuity improved by 0.27 (p = 0.001), 0.18 (p = 0.02), 0.17 (p = 0.025), and 0.07 logMAR units (p &gt; 0.1); and ECC changed by +7.0 (p &gt; 0.1), 15.4 (p &gt; 0.1), \u22127.6 (p &gt; 0.1), and 2.3 cells\/mm2 (p &gt; 0.1) in the post-cataract surgery, FECD, post-DMEK, and post-PKP groups, respectively. Conclusions: No adverse events or progression of edema were recorded during the follow-up period. These findings support the role of Ripasudil as a non-invasive pharmacological approach to managing corneal edema and delaying or possibly avoiding surgical interventions, such as corneal transplantation, in selected cases.<\/jats:p>","DOI":"10.3390\/jcm14155572","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T10:58:26Z","timestamp":1754564306000},"page":"5572","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical Evaluation of Ripasudil for Corneal Edema: A Large-Scale Retrospective Cohort Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3327-0173","authenticated-orcid":false,"given":"Nir","family":"Erdinest","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Hadassah University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Tabi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadav","family":"Shemesh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hadassah University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamel","family":"Corredores","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hadassah University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7747-3568","authenticated-orcid":false,"given":"Claudia","family":"Yahalom","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hadassah University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yossi","family":"Eshel","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hadassah University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6659-9616","authenticated-orcid":false,"given":"Benjamin","family":"Stern","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hadassah University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4168-056X","authenticated-orcid":false,"given":"David","family":"Smadja","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hadassah University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zvi","family":"Gur","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hadassah University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5213-3196","authenticated-orcid":false,"given":"Itay","family":"Lavy","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hadassah University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/ICO.0000000000002652","article-title":"Review on the use of topical ocular hypertonic saline in corneal edema","volume":"40","author":"Chow","year":"2021","journal-title":"Cornea"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/ICO.0000000000002421","article-title":"Case series: Novel utilization of rho-kinase inhibitor for the treatment of corneal edema","volume":"40","author":"Davies","year":"2021","journal-title":"Cornea"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Juki\u0107, A., Pupi\u0107 Bakra\u010d, A., \u0110apic Ivan\u010di\u0107, B., Kopi\u0107, A., Meter, A., Kasalica \u017du\u017eul, R., Pavan, J., and Juki\u0107, T. (2025). Rho-Kinase Inhibitors in the Management of Fuchs Endothelial Corneal Dystrophy: A Review. Medicina, 61.","DOI":"10.3390\/medicina61050772"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13256-021-02665-0","article-title":"Rhopressa-induced corneal edema: A case report","volume":"15","author":"Chu","year":"2021","journal-title":"J. Med. Case Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/sj.eye.6700574","article-title":"Transparency, swelling and scarring in the corneal stroma","volume":"17","author":"Meek","year":"2003","journal-title":"Eye"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jtos.2024.08.003","article-title":"Evolution of therapeutic strategy based on oxidant-antioxidant balance for fuchs endothelial corneal dystrophy","volume":"34","author":"Wu","year":"2024","journal-title":"Ocul. Surf."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/opo.13414","article-title":"What intrinsic factors affect the central corneal thickness?","volume":"45","author":"Linhares","year":"2025","journal-title":"Ophthalmic Physiol. Opt."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"101242","DOI":"10.1016\/j.ajoc.2021.101242","article-title":"Therapeutic contact lens for Fuchs endothelial corneal dystrophy: Monitoring with Scheimpflug tomography","volume":"25","author":"Erdinest","year":"2022","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/01.ico.0000214225.98366.83","article-title":"Pseudophakic corneal edema: A review of mechanisms and treatments","volume":"25","author":"Narayanan","year":"2006","journal-title":"Cornea"},{"key":"ref_10","first-page":"149","article-title":"Topical hyperosmolar solutions in the reduction of corneal edema","volume":"13","author":"Insler","year":"1987","journal-title":"Eye Contact Lens"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/ICO.0000000000000693","article-title":"Corneal tattooing and anterior stromal puncture for treating symptomatic bullous keratopathy","volume":"35","author":"Lin","year":"2016","journal-title":"Cornea"},{"key":"ref_12","first-page":"699","article-title":"Primary bullous keratopathy in a patient With Werner syndrome treated With corneal transplant","volume":"17","author":"Singh","year":"2019","journal-title":"Exp. Clin. Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/bmj.333.7559.128","article-title":"Cataract and surgery for cataract","volume":"333","author":"Allen","year":"2006","journal-title":"BMJ"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Yi, D.H., and Dana, M.R. (2002). Corneal edema after cataract surgery: Incidence and etiology. Seminars in Ophthalmology, Taylor & Francis.","DOI":"10.1076\/soph.17.3.110.14737"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ishikawa, S., Kato, N., and Takeuchi, M. (2018). Quantitative evaluation of corneal epithelial edema after cataract surgery using corneal densitometry: A prospective study. BMC Ophthalmol., 18.","DOI":"10.1186\/s12886-018-0998-5"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.jcrs.2014.10.033","article-title":"Oxygen therapy for corneal edema after cataract surgery","volume":"41","author":"Sharifipour","year":"2015","journal-title":"J. Cataract Refract. Surg."},{"key":"ref_17","first-page":"505","article-title":"Transient corneal edema after phacoemulsification","volume":"25","author":"Kausar","year":"2015","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"D\u00edez-Ajenjo, M.A., Luque-Cobija, M.J., Peris-Mart\u00ednez, C., Ort\u00ed-Navarro, S., and Garc\u00eda-Domene, M.C. (2022). Refractive changes and visual quality in patients with corneal edema after cataract surgery. BMC Ophthalmol., 22.","DOI":"10.1186\/s12886-022-02452-5"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/tvst.10.4.18","article-title":"The ROCK inhibitor ripasudil shows an endothelial protective effect in patients with low corneal endothelial cell density after cataract surgery","volume":"10","author":"Fujimoto","year":"2021","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.26502\/fjor.2644-00240041","article-title":"Efficacy of the Rho-kinase Inhibitor Ripasudil for Fuchs\u2019 endothelial corneal dystrophy","volume":"4","author":"Fujimoto","year":"2021","journal-title":"J. Ophthalmol. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/IJG.0000000000001203","article-title":"Long-term side effects including blepharitis leading to discontinuation of ripasudil","volume":"28","author":"Saito","year":"2019","journal-title":"J. Glaucoma"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/jop.2019.0125","article-title":"Safety and efficacy of long-term ripasudil 0.4% instillation for the reduction of intraocular pressure in Japanese open-angle glaucoma patients","volume":"36","author":"Maruyama","year":"2020","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/ICO.0000000000003698","article-title":"Preoperative Posterior Stromal Ripples as Predictive Biomarkers of Visual Recovery After Descemet Membrane Endothelial Keratoplasty","volume":"44","author":"Ventura","year":"2025","journal-title":"Cornea"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1111\/aos.15250","article-title":"Posterior stromal ripples increase risk of Descemet\u2019s membrane endothelial keratoplasty graft detachment worsening over time","volume":"101","author":"Coco","year":"2023","journal-title":"Acta Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1007\/s00417-024-06452-7","article-title":"Effects of graft detachment on the central corneal thickness after uncomplicated Descemet membrane endothelial keratoplasty","volume":"262","author":"Lohmann","year":"2024","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s00417-024-06383-3","article-title":"Predictive factors for re-bubbling after DMEK: Focus on the posterior corneal surface","volume":"262","author":"Kilian","year":"2024","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1097\/ICO.0000000000003812","article-title":"Letter Regarding: Analysis of Graft Detachments and Re-Bubblings After 450 Descemet Membrane Endothelial Keratoplasty Procedures","volume":"44","author":"Parekh","year":"2025","journal-title":"Cornea"},{"key":"ref_28","first-page":"361","article-title":"Rock inhibitors: Future of antiglaucoma medication","volume":"2","author":"Vohra","year":"2014","journal-title":"Ophthalmol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/ceo.14224","article-title":"ROCK inhibitors in ophthalmology: A critical review of the existing clinical evidence","volume":"51","author":"Karri","year":"2023","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Tanihara, H., Kakuda, T., Sano, T., Kanno, T., and Gunji, R. (2020). Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study. BMC Ophthalmol., 20.","DOI":"10.1186\/s12886-020-01490-1"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s12325-021-02023-y","article-title":"Long-term intraocular pressure-lowering effects and adverse events of ripasudil in patients with glaucoma or ocular hypertension over 24 months","volume":"39","author":"Tanihara","year":"2022","journal-title":"Adv. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.2147\/DDDT.S515166","article-title":"Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions","volume":"19","author":"Chatzimichail","year":"2025","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/ICO.0000000000002437","article-title":"Descemet stripping only supplemented with topical ripasudil for Fuchs endothelial dystrophy 12-month outcomes of the Sydney Eye Hospital Study","volume":"40","author":"Moloney","year":"2021","journal-title":"Cornea"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajo.2020.12.006","article-title":"Potential functional restoration of corneal endothelial cells in Fuchs endothelial corneal dystrophy by ROCK inhibitor (Ripasudil)","volume":"224","author":"Zenkel","year":"2021","journal-title":"Am. J. Ophthalmol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/ICO.0000000000003282","article-title":"Topical Ripasudil for the Treatment of Segmental Corneal Edema: A Case Series","volume":"42","author":"Tseng","year":"2023","journal-title":"Cornea"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"101245","DOI":"10.1016\/j.ajoc.2021.101245","article-title":"Rho-associated kinase inhibitor eye drops in challenging cataract surgery","volume":"25","author":"Antonini","year":"2022","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s40123-024-00950-x","article-title":"The Protective Effect of Rho-Associated Kinase Inhibitor Eye Drops (Ripasudil) on Corneal Endothelial Cells After Cataract Surgery: A Prospective Comparative Study","volume":"13","author":"Alkharashi","year":"2024","journal-title":"Ophthalmol. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/ICO.0000000000002270","article-title":"5-year outcomes of Descemet stripping only in Fuchs dystrophy","volume":"39","author":"Artieda","year":"2020","journal-title":"Cornea"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1167\/iovs.17-22106","article-title":"Allogeneic Descemet\u2019s membrane transplantation enhances corneal endothelial monolayer formation and restores functional integrity following Descemet\u2019s stripping","volume":"58","author":"Bhogal","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jcrs.2004.09.031","article-title":"Influence of corneal biomechanical properties on intraocular pressure measurement: Quantitative analysis","volume":"31","author":"Liu","year":"2005","journal-title":"J. Cataract Refract. Surg."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/IJG.0b013e31824cef11","article-title":"The impact of corneal edema on intraocular pressure measurements using goldmann applanation tonometry, Tono-Pen XL, iCare, and ORA: An in vitro model","volume":"22","author":"Neuburger","year":"2013","journal-title":"J. Glaucoma"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Briceno-Lopez, C., Burguera-Gim\u00e9nez, N., Garc\u00eda-Domene, M.C., D\u00edez-Ajenjo, M.A., Peris-Mart\u00ednez, C., and Luque, M.J. (2023). Corneal edema after cataract surgery. J. Clin. Med., 12.","DOI":"10.3390\/jcm12216751"},{"key":"ref_43","first-page":"815","article-title":"Tonometry in corneal edema after cataract surgery: Dynamic contour tonometry versus Goldmann applanation tonometry","volume":"7","author":"Herr","year":"2013","journal-title":"Clin. Ophthalmol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3109\/02713683.2014.888451","article-title":"Tonometry in corneal edema after cataract surgery: Rebound versus goldmann applanation tonometry","volume":"39","author":"Fuest","year":"2014","journal-title":"Curr. Eye Res."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Minami, Y., Song, Y.-S., Ishibazawa, A., Omae, T., Ro-Mase, T., Ishiko, S., and Yoshida, A. (2019). Effect of ripasudil on diabetic macular edema. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-40194-5"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/15\/5572\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:25:23Z","timestamp":1760034323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/15\/5572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":45,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["jcm14155572"],"URL":"https:\/\/doi.org\/10.3390\/jcm14155572","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]}}}